東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Interleukin-27 = biological properti...

Jankowski, Marek.

FindBook

Google Book

Amazon

博客來

Interleukin-27 = biological properties and clinical application /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Interleukin-27/ by Marek Jankowski, Tomasz Wandtke.
其他題名:	biological properties and clinical application /
作者:	Jankowski, Marek.
其他作者:	Wandtke, Tomasz.
出版者:	Cham :Springer International Publishing : : 2016.,
面頁冊數:	vi, 86 p. :ill., digital ;24 cm.
內容註:	IL-27: Structure, Regulation and Variability -- IL-27: A Key Player in Immune Regulation -- IL-27 in Health and Disease.
Contained By:	Springer eBooks
標題:	Interleukins. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-39664-4
ISBN:	9783319396644

Interleukin-27 = biological properties and clinical application /
Jankowski, Marek.

Interleukin-27biological properties and clinical application /[electronic resource] :by Marek Jankowski, Tomasz Wandtke. - Cham :Springer International Publishing :2016. - vi, 86 p. :ill., digital ;24 cm. - SpringerBriefs in immunology,2194-2773. - SpringerBriefs in immunology..

IL-27: Structure, Regulation and Variability -- IL-27: A Key Player in Immune Regulation -- IL-27 in Health and Disease.

This volume focuses on various aspects of interleukin-27 (IL-27), especially its potential for clinical applications. The authors discuss the downstream signaling from the IL-27 receptor and its molecular targets in immune cells including Th1, Th2, Th17, Treg, Tr1, Tfh, B cells, DCs and macrophages. The inhibition of Th17 cells by IL-27 is vital for the maintenance of the feto-maternal tolerance and the prevention of lupus, multiple sclerosis, autoimmune uveitis, immune thrombocytopenia and atherosclerosis. However, the same inhibitory capabilities compromise the immune response to bacterial pathogens, and IL-27 is a pathogenic factor in sepsis and tuberculosis. Also covered are the conflicting reports on the role of IL-27 in rheumatoid arthritis, the effect of IL-27 on epithelia, which seems to play a role in asthma, psoriasis and inflammatory bowel diseases, and the direct cytotoxic and anti-vascular effects of IL-27, which make it a promising agent for the treatment of cancer. Accordingly, this volume will be of interest to researchers and clinicians alike.

ISBN: 9783319396644

Standard No.: 10.1007/978-3-319-39664-4doiSubjects--Topical Terms:

2194691
Interleukins.

LC Class. No.: QR185.8.I56

Dewey Class. No.: 571.96

Interleukin-27 = biological properties and clinical application /
LDR:02222nmm a2200325 a 4500 001 2037861
003 DE-He213
005 20161019143641.0
006 m d
007 cr nn 008maaau
008 161209s2016 gw s 0 eng d
020 $a 9783319396644 $q (electronic bk.)
020 $a 9783319396620 $q (paper)
024 7 $a 10.1007/978-3-319-39664-4 $2 doi
035 $a 978-3-319-39664-4
040 $a GP $c GP
041 0 $a eng
050 4 $a QR185.8.I56
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
082 0 4 $a 571.96 $2 23
090 $a QR185.8.I56 $b J33 2016
100 1 $a Jankowski, Marek. $3 2194689
245 1 0 $a Interleukin-27 $h [electronic resource] : $b biological properties and clinical application / $c by Marek Jankowski, Tomasz Wandtke.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a vi, 86 p. : $b ill., digital ; $c 24 cm.
490 1 $a SpringerBriefs in immunology, $x 2194-2773
505 0 $a IL-27: Structure, Regulation and Variability -- IL-27: A Key Player in Immune Regulation -- IL-27 in Health and Disease.
520 $a This volume focuses on various aspects of interleukin-27 (IL-27), especially its potential for clinical applications. The authors discuss the downstream signaling from the IL-27 receptor and its molecular targets in immune cells including Th1, Th2, Th17, Treg, Tr1, Tfh, B cells, DCs and macrophages. The inhibition of Th17 cells by IL-27 is vital for the maintenance of the feto-maternal tolerance and the prevention of lupus, multiple sclerosis, autoimmune uveitis, immune thrombocytopenia and atherosclerosis. However, the same inhibitory capabilities compromise the immune response to bacterial pathogens, and IL-27 is a pathogenic factor in sepsis and tuberculosis. Also covered are the conflicting reports on the role of IL-27 in rheumatoid arthritis, the effect of IL-27 on epithelia, which seems to play a role in asthma, psoriasis and inflammatory bowel diseases, and the direct cytotoxic and anti-vascular effects of IL-27, which make it a promising agent for the treatment of cancer. Accordingly, this volume will be of interest to researchers and clinicians alike.
650 0 $a Interleukins. $3 2194691
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Immunology. $3 611031
650 2 4 $a Cytokines and Growth Factors. $3 1084957
700 1 $a Wandtke, Tomasz. $3 2194690
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a SpringerBriefs in immunology. $3 2133251
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-39664-4
950 $a Biomedical and Life Sciences (Springer-11642)